VZV meningitis following varicella vaccine

Journal of Clinical Virology

Volumn 48, Issue 4, 2010, Pages 275-277

  Fusco, Dahlene ^a   Krawitz, Peter ^b   LaRussa, Philip ^c   Steinberg, Sharon ^c   Gershon, Anne ^c   Jacobs, Jonathan ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c College of Physicians and Surgeons ^*  (United States)

Author keywords

Disseminated herpes zoster; Vaccine; Varicella

Indexed keywords

ACICLOVIR; FAMCICLOVIR; VARICELLA ZOSTER VACCINE; CHICKENPOX VACCINE; LIVE VACCINE; VIRUS DNA;

AGED; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CHICKENPOX; CONFUSION; COUGHING; DRUG WITHDRAWAL; FEMALE; FEVER; HEMODYNAMIC PARAMETERS; HERPES ZOSTER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MENINGOENCEPHALITIS; PAIN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SINGLE DRUG DOSE; TACHYCARDIA; TACHYPNEA; TREATMENT WITHDRAWAL; VACCINATION; VARICELLA MENINGOENCEPHALITIS; VESICULAR RASH; WILD TYPE; ENCEPHALITIS, VARICELLA ZOSTER; GENETICS; ISOLATION AND PURIFICATION; VARICELLA ZOSTER VIRUS; VIROLOGY;

AGED; CHICKENPOX VACCINE; DNA, VIRAL; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; VACCINES, ATTENUATED;

EID: 77954657058     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.04.014     Document Type: Article

References (10)

1. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352(22):2271-2284.
2. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001, 32(10):1481-1486.
3. Weibel R.E., Neff B.J., Kuter B.J., Guess H.A., Rothenberger C.A., Fitzgerald A.J., et al. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med 1984, 310(22):1409-1415.
4. Berger R., Trannoy E., Hollander G., Bailleux F., Rudin C., Creusvaux H. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older. J Infect Dis 1998, 178(Suppl. 1):S99-103.
5. Burke B.L., Steele R.W., Beard O.W., Wood J.S., Cain T.D., Marmer D.J. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982, 142(2):291-293.
6. Trannoy E., Berger R., Hollander G., Bailleux F., Heimendinger P., Vuillier D., et al. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine 2000, 18(16):1700-1706.
7. LaRussa P., Lungu O., Hardy I., Gershon A., Steinberg S.P., Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992, 66(2):1016-1020.
8. Parker S.P., Quinlivan M., Taha Y., Breuer J. Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J Clin Microbiol 2006, 44(11):3911-3914.
9. Cinque P., Bossolasco S., Vago L., Fornara C., Lipari S., Racca S., et al. Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?. Clin Infect Dis 1997, 25(3):634-639.
10. Hornig M., Briese T., Buie T., Bauman M.L., Lauwers G., Siemetzki U., et al. Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS ONE 2008, 3:e3140.